Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation.
about
Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerHeterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes.Alcohol drinking as an unfavorable prognostic factor for male patients with nasopharyngeal carcinoma.Heterogeneous impact of alcohol consumption according to treatment method on survival in head and neck cancer: A prospective study.Molecular targeting in combination with platinum-based chemoradiotherapy in head and neck cancer treatment.Primary treatment for oropharyngeal squamous cell carcinoma in Alberta, Canada: A population-based study.Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma - a European singleinstitution analysis.No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression.Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery.Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure
P2860
Q26782255-91E9B365-0CFD-46F6-998C-FAF73BC3AE84Q35756750-9816A359-3426-4F58-8D94-EF5004239B18Q35832792-1359BAAF-D2F3-4C69-8C1F-137F59158CF3Q36499706-78E99F87-FC26-4767-8CBC-248B4FEDF4EBQ37611653-2060642C-D28A-4002-91D6-38DDCEFF5ADFQ38382066-760F4315-96F3-46D1-982E-9C32F348A32CQ38637666-B05501EF-89EB-4166-8990-3DB8285CC2B8Q39761858-BF1B1AA3-1241-4B28-935F-AA2AEAC983B4Q41683201-41A1B36F-06C1-4C4E-834B-A50CE51082B2Q42240615-7D4AA3BE-43D1-4D93-8B25-E300799F42DCQ47407081-5FE70D42-9BFE-4CD0-8AAA-E1652411F135Q48154001-13889F81-53EC-4E7A-8F1E-B91D0B2CE4B4Q53063987-A66A9941-AC97-4038-867D-27462D66604CQ54548108-1F099918-8DCC-420B-ADFC-764F90DA3BA4Q58792602-CCE88037-FB02-4070-B549-D7EF957580E5
P2860
Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Impact of p16, p53, smoking, a ...... sity-modulated chemoradiation.
@en
Impact of p16, p53, smoking, a ...... sity-modulated chemoradiation.
@nl
type
label
Impact of p16, p53, smoking, a ...... sity-modulated chemoradiation.
@en
Impact of p16, p53, smoking, a ...... sity-modulated chemoradiation.
@nl
prefLabel
Impact of p16, p53, smoking, a ...... sity-modulated chemoradiation.
@en
Impact of p16, p53, smoking, a ...... sity-modulated chemoradiation.
@nl
P2093
P2860
P356
P1433
P1476
Impact of p16, p53, smoking, a ...... sity-modulated chemoradiation.
@en
P2093
Alex Soltermann
David Rohrbach
Gabriela Studer
Gerard F Huber
Holger Moch
Martina A Broglie
Sandro J Stoeckli
Sarah R Haile
P2860
P304
P356
10.1002/HED.23231
P577
2013-03-18T00:00:00Z